Electropermeabilization Signal Techniques
Electropermeabilization Signal Techniques
www.elsevier.com/locate/bioelechem
Review
Techniques of signal generation required for electropermeabilization.
Survey of electropermeabilization devices
Marko Puc, Selma Čorović, Karel Flisar, Marko Petkovšek, Janez Nastran, Damijan Miklavčič *
Damijan Miklavčič, University of Ljubljana, Faculty of Electrical Engineering, Tržaška 25, SI-1000 Ljubljana, Slovenia
Received 27 November 2003; received in revised form 23 January 2004; accepted 8 April 2004
Available online 15 June 2004
Abstract
Electropermeabilization is a phenomenon that transiently increases permeability of the cell plasma membrane. In the state of high
permeability, the plasma membrane allows ions, small and large molecules to be introduced into the cytoplasm, although the cell plasma
membrane represents a considerable barrier for them in its normal state. Besides introduction of various substances to cell cytoplasm,
permeabilized cell membrane allows cell fusion or insertion of proteins to the cell membrane. Efficiency of all these applications strongly
depends on parameters of electric pulses that are delivered to the treated object using specially developed electrodes and electronic devices—
electroporators. In this paper we present and compare most commonly used techniques of signal generation required for
electropermeabilization. In addition, we present an overview of commercially available electroporators and electroporation systems that
were described in accessible literature.
D 2004 Elsevier B.V. All rights reserved.
1567-5394/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bioelechem.2004.04.001
114 M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124
Fig. 1. Exposure of a cell to an electric field may result either in permeabilization of cell membrane or its destruction. In this process the electric field
parameters play a major role. If these parameters are within certain range, the permeabilization is reversible, therefore it can be used in applications such as
introduction of small or large molecules into the cytoplasm, insertion of proteins into cell membrane or cell fusion.
evident that threshold value of electric field varies with cell the required signal to its output loaded by impedance of
size. This means that large cells are more sensitive to lower sample between electrodes.
electric field strengths than small cells [7,9]. Moreover, it has Probably the major problem that every engineer faces
been shown that induced transmembrane potential difference during the design of electroporator is characterization of the
also depends on cell density, arrangement and cell position load, which in principle has resistive and capacitive com-
[17 –19]. Considering this, it is very difficult to generalize the ponent. The value of each component is defined by geom-
electric field parameters for different experimental conditions etry and material of electrodes and by electrical and
(i.e. single cell permeabilization, in vitro, in vivo, etc.), or for chemical properties of the treated sample. In in vitro
different cell types (i.e. animal, plant, fungi, prokaryotic). In conditions these parameters that influence on impedance
addition, different applications require different time varia- of load can be well controlled since size and geometry of
tion of electric fields (i.e. exponentially decaying, square sample is known especially if cuvettes are used, furthermore
wave, etc.) and different exposure times. by using specially prepared cell mediums electrical and
It is not an aim of this paper to focus on further chemical properties are defined or can be measured [27 –
description of electric field parameters that are required in 30]. On the other hand, in in vivo or clinical conditions, size
different applications of electropermeabilization. Instead, and geometry can still be controlled to a certain extent but
we would like to present and compare advantages and electrical and chemical properties can only be estimated.
drawbacks of the existing and most commonly used con- But what is practically impossible to predict during the
cepts of electric signal generation and available devices that development of the device are changes in the electrical and
fulfill electrical requirements of applications such as: elec- chemical properties of the sample due to exposure to high-
trochemotherapy, electrotransfection, insertion of proteins voltage electric pulses. Besides electropermeabilization of
into cell membrane, cell fusion and transdermal drug deliv- cell membranes which increases electrical conductivity of
ery [5– 7,15,20 –23]. the sample [31 – 33,38,39], electric pulses also cause at least
two known side effects: heating and electrolytic contami-
nation of the sample [10,34 –37]. Furthermore, there are
2. Techniques of signal generation required for several other side effects that evolve from interactions
electropermeabilization between electrodes and treated sample, but we will not
explain their influence on electrical and chemical properties
Effectiveness of electropermeabilization in either in vitro, of the sample because this is beyond the scope of this paper.
in vivo or clinical environment depends on the distribution When most of the electrical parameters that electropo-
of electric field inside the treated sample [24 – 26]. To rator should provide are determined, engineer has to choose
achieve this, we have to use an appropriate set of electrodes the type of electroporator he is going to design. In principle,
(e.g. needle, parallel plates, cuvettes, etc.) and an electro- electroporators can be divided in several groups depending
permeabilization device—electroporator that generates re- on the biological applications, but from the electrical point
quired voltage or current signals. Although both parts of the of view only two types of electroporators exist: devices with
mentioned equipment are equally important for effective- voltage output (output is voltage signal U(t)) and devices
ness of electropermeabilization, electroporator has substan- with current output (output is current signal I(t)). Both types
tially more important role since it has to be able to deliver of devices have their advantages and disadvantages, but one
M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124 115
Table 1
Comparison of presented techniques of signal generation for electro-
permeabilization
Technique Advantages Disadvantages
Discharge of capacitor – simple and – poor flexibility of
inexpensive parameters
construction
Square wave – simple construction – limitation of output
generator (power – better control of parameters due to
transistors) pulse parameters semiconductor
technology
Square wave – very safe – limitations of pulse
generator (pulse (possibility to use in duration and
transformer) clinical environment) repetition frequency
– very high pulse – complex design of
amplitudes pulse transformer
Analogue generator of – wide flexibility of – limitation of output
unipolar arbitrary pulse parameters current and voltage
signals – arbitrary signal due to semiconductor
shape technology
Analogue generator of – genuine bipolar – limitation of
Fig. 7. Simplified circuit of modular high-voltage source. Operation of the bipolar arbitrary arbitrary signals bandwidth, output
device is based on a principle of digital-to-analogue converter, thus the signals – arbitrary signal current and voltage
device comprises several (N) individually controlled electrically isolated DC shape due to semiconductor
voltage modules, where the amplitude of the particular voltage source VN is technology
twice as high as in the preceding module. With an appropriate control of Modular high voltage – high dynamics – price
output transistors Q1 – QN the modules are connected in series and a total of source – high currents and
2N different output voltage levels with the resolution of V1 are obtained [48]. voltages
118 M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124
Table 2
List of commercially available electroporators with their parameters, biological applications and possible signal generation technique
Company/product Output Voltage range Time constant Charge time (tc)/pulse Biological application Possible signal
characteristics (s)/pulse length (T) repetition frequency generation technique
( f)
ADITUS MEDICAL http://www.aditusmedical.com
CythorLab Arbitrary LV: 0 V – 600 Vpp, LV: T = 400 ms NA in vitro, in vivo NA
HV: 0 V – 3000 Vpp HV: T = 5 ms
BIORAD http://www.biorad.com
Micro Pulser Exponential 200 – 3000 V s = 1 – 4 ms tc = 5 s bacterial, yeast Capacitor discharge
Gene Pulser Xcell Exponential 10 – 3000 V s = 0.5 ms – 3.3 s tc = 5 s all cell type, eukaryotic Capacitor discharge
Square wave T = 0.05 – 10 ms f = 0.1 – 10 Hz and prokaryotic cells
BTX http://www.btxonline.com
ECM 399 Exponential LV: 2 – 500 V LV: s = 157 ms tc < 5 s bacterial, yeast, Capacitor discharge
HV: 10 – 2500 V HV: s = 5.4 ms mammalian
ECM 630 Exponential LV: 10 – 500 V LV: s = 25 As – 5 s tc < 5 s bacterial, yeast, Capacitor discharge
HV: 50 – 2500 V HV:s = 625 As – 78 ms mammalian, plant,
in vivo
ECM 830 Square wave LV: 5 – 500 V LV: T = 10 As – 10 s f = 0.1 – 10 Hz bacterial, yeast, LV: square wave
HV: 30 – 3000 V HV: T = 10 – 600 As mammalian, plant, generator HV: pulse
in vivo, in ovo transformer
ECM 2001 Square wave LV: 10 – 500 V LV: T = 10 As – 99 ms NA mammalian, plant, LV: square wave
HV: 10 – 3000 V HV: T = 1 – 99 As NA electrofusion generator
Sinus (AC) 0 V – 150 Vpp fAC = 1 MHz HV: pulse transformer
AC: NA
HT 3000 Square wave LV: 0 – 500 V LV: T = 10 ms – 1 s f = 0.1 – 10 Hz in vitro LV: square wave
HV: 0 – 3000 V HV: T = 10 – 600 ms generator HV: pulse
transformer
CLONAID http://www.clonaid.com
RMX2010 Square wave 5 – 200 V T = 10 As – 990 ms f = 1 – 10 Hz gene transfection Square wave generator
EQUIBIO http://www.equibio.com
Easyjec T Plus Exponential 100 – 3500 V s = 10 As – 7 s NA all cell types Capacitor discharge
Easyjec T Optima Exponential 20 – 2500 V s = 1.5 ms – 7 s NA all cell types Capacitor discharge
Easyjec T Prima Exponential 1800 – 2500 V s = 5 ms NA bacterial Capacitor discharge
GENETRONICS http://www.genetronics.com
MEDPULSER Square wave NA NA NA electrochemotherapy, NA
clinical device
IGEA http://www.igea.it
Cliniporator Square wave LV: 20 – 200 V LV: T = 10 As – 20 ms f = 1 Hz – 10 kHz electrochemotherapy, unipolar arbitrary
HV: 50 – 1000 V HV: T = 30 – 200 As gene therapy, clinical generator
device
M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124 119
Table 2 (continued)
Company/product Output Voltage range Time constant Charge time (tc)/pulse Biological application Possible signal
characteristics (s)/pulse length (T) repetition frequency generation technique
( f)
JOUAN
Electropulsator Square wave 0 – 1000 V T = 5 As – 24 ms f = 1 – 10 Hz bacterial, yeast, Square wave generator
PS10 mammalian, plant
Electropulsator Square wave 0 – 1500 V T = 5 As – 24 ms f = 1 – 10 Hz bacterial, yeast, Square wave generator
PS15 mammalian, plant
type for positive and NPN-type for negative period) modules (Fig. 7). Its operation is based on a principle of a
connected in cascade and a resistor network necessary for digital-to-analog converter, thus the amplitude of the partic-
normal operation. At this point it has to be stressed that ular source V N is twice as high as the predecessor
complementary transistors have to be used (i.e. NPN and (VN = 2VN 1). The voltage of the individual source is con-
PNP type which are close match) otherwise symmetry stant and can participate in a generation of a common output
between positive and negative part of amplifier cannot be pulse at any time. With an appropriate control of output
achieved. The two signals amplified in each transconduc- transistors Q1 –QN that operate as switches and connect the
tance stage are delivered to two output stages, again one for modules in series, a total of 2N different output voltage levels
positive and one for negative period of signal. The output with the resolution of V1 are obtained [48]. Although the
stages are composed of power MOSFETs, if possible design of each individual source is similar to the design of
complementary (N-type for positive and P-type for negative previously described square wave pulse generator, the indi-
period), that are connected in cascade as source followers. vidual source used in this concept has no problems with the
These last two stages recombine two signals from voltage shortage of power. For correct operation, each source (even
amplifier and meet the power requirements defined by the the smallest one) must be able to produce and sustain the
impedance of the load between electrodes [47]. maximum possible current during the pulse generation. If this
Although, the design by itself has no problems and is is not ensured, the pulse amplitude will decrease.
given as an example in any electronic design book, the major The presented modular topology has many advantages
problem originates in poor availability of semiconductor due to very high dynamics and high power that can be
components (i.e. high voltage and high power complemen- delivered to its output. Furthermore, with a supplemented
tary transistors) necessary to build each of the amplifying single-phase transistor bridge on the output, bipolar pulses
stage. Since those transistors exist only up to 250 V, undesired can be generated as well. Besides the electrode polarity
cascades that gradually reduce dynamics have to be used to change, the transistor bridge also increases the incorporated
generate signals required for electropermeabilization. safety measures of the device in case of malfunction, which
could result in a delivery of huge power to the output.
2.5. Modular high voltage source Namely, for any given pulse amplitude at least three power
transistor switches have to be turned ON (two for the
Another possible improvement of a square wave generator selection of the pulse polarity and at least one for the
is a modular high voltage source that consists of several (N) selection of the desired output pulse amplitude). The mod-
individually controlled and electrically isolated DC voltage ular solution and consequently the increased number of
120 M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124
Table 3
List of commercially available electrodes with their properties and biological applications suggested by manufacturer
Company/product Number of Electrode Needle length (L)/electrode Electrode Biological
electrodes distance size (shape)/Volume (V) material application
BIORAD http://www.biorad.com
CUVETTES: Compatible with Micro pulser, Gene Pulser Xcell
2 1 mm V = 100 Al Aluminum in vitro
2 2 mm V = 400 Al Aluminum in vitro
2 4 mm V = 800 Al Aluminum in vitro
BIOSMITH http://www.biosmith.com
CUVETTES: Compatible with electroporation devices from all major manufacturers
72001 2 1 mm V = 100 Al Aluminum in vitro
72002 2 2 mm V = 400 Al Aluminum in vitro
72004 2 4 mm V = 800 Al Aluminum in vitro
BTX http://www.btxonline.com
2-NEEDLE ARRAY: Compatible with: ECM 830, 630, 395, 399, 600, T820
Model 531 2 10 mm L = 200 mm Stainless in vivo
steel
Model 532 2 5 mm L = 200 mm Stainless in vivo
steel
GENETRODES: Compatible with: ECM 630, 830, 2001, 600, T820
Model 508 2 1 – 10 mm L = 5 mm Gold plating in vivo
Model 510 2 1 – 10 mm L = 10 mm Gold plating in vivo
Model 512 2 0 – 13 mm L = 5 mm (L-shaped) Gold plating in ovo
Model 514 2 0 – 13 mm L = 3 mm (L-shaped) Gold plating in ovo
Model 516 2 0 – 13 mm L = 1 mm (L-shaped) Gold plating in ovo
CALIPER: Compatible with: ECM 830, 600, 630, 2001, T820
Model 384 2 1 – 130 mm 10 10 mm (square) Stainless steel in vivo
Model 384L 2 1 – 130 mm 20 20 mm (square) Stainless steel in vivo
TWEZERTRODES: Compatible with: ECM T820, 630, 830, 2001
Model 520 2 1 – 20 mm 7 mm diameter (disk) Stainless steel in vivo
Model 522 2 1 – 20 mm 10 mm diameter (disk) Stainless steel in vivo
GENEPADDLES: Compatible with: ECM 830, 2001, 630, 600, T820
Model 542 2 1 – 10 mm 3 5 mm (rectangle) Gold plating in vitro, in vivo
Model 543 2 1 – 10 mm 5 7 mm (rectangle) Gold plating in vitro, in vivo
PETRI PULSER: Compatible with: ECM 830, 630, 600, 399, 395, T820
PP35-2P 13 2 mm V = 0.5 – 30 ml Gold plating in vitro
PETRI DISH ELECTRODES: Compatible with:ECM 830, 630, 2001, 600, T 820
24 2 mm V = 10 – 50 ml Stainless steel in vitro
BTX http://www.btxonline.com
MICROSLIDE: Compatible with: ECM 630, 830, 395, 399, 2001, 600, T820
Model 450 2 0.5 mm V = 20 Al Stainless steel in vitro, fusion
Model 450-1 2 1 mm V = 40 Al Stainless steel in vitro, fusion
Model 453 2 3.2 mm V = 0.7 ml Stainless steel in vitro, fusion
Model 453-10 2 10 mm V = 2.2 ml Stainless steel in vitro, fusion
FLAT ELECTRODE CHAMBER: Compatible with: ECM 630, 830, 2001, 600, T820
Model 484 2 1 mm V = 0.5 ml Stainless steel in vitro, fusion
Model 482 2 2 mm V = 1 ml Stainless steel in vitro, fusion
MEANDER FUSION CHAMBER: Compatible with: ECM 630, 830, 2001, 200, 600, T820
2 0.2 mm – Silver in vitro, fusion
Electroporation plates:
Model HT-P96-2B/W 96 2 mm V = 150 Al Gold plating in vitro
Model HT-P96-4B/W 96 4 mm V = 300 Al Gold plating in vitro
Model HT-P384-2B/W 384 2 mm V = 700 Al Gold plating in vitro
MULTI-WELL COAXIAL ELECTRODES: Compatible with: ECM 630, 830, 2001, 600, T820
Model 491-1 1 1.6 mm V = 0.3 ml (circular) Gold plating in vitro
Model 747 8 1.6 mm V = 0.3 ml (circular) Gold plating in vitro
Model 840 96 1.6 mm V = 0.3 ml (circular) Gold plating in vitro
Flatpack chambers:
Model 485 2 1.83 mm V = 1.5 ml Stainless steel in vitro
M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124 121
Table 3 (continued)
EPPENDORF http://www.eppendorf.com
CUVETTES: Compatible with Multiporator, Electroporator 2510
2 1 mm V = 100 Al Aluminum in vitro
2 2 mm V = 400 Al Aluminum in vitro
2 4 mm V = 800 Al Aluminum in vitro
CYTOPULSE http://www.cytopulse.com
COAXIAL ELECTRODES: Compatible with PA-101
Model FE-C25/400 2 2.5 mm V = 350 ml NA in vitro, fusion
Model FE-C25/800 2 2.5 mm V = 750 ml NA in vitro, fusion
Model FE-C20/1000 2 2 mm V = 1000 ml NA in vitro, fusion
Tweezers:
TE-5-10 2 Adjustable 5 10 mm (rectangular) NA in vivo
TE-5R 2 Adjustable 5 mm diameter (circular) NA in vivo
2-row needle array:
NE-4-4 8 4 mm NA in vivo
NE-4-6 12 4 mm NA in vivo
NE-6-4 8 6 mm NA in vivo
NE-6-6 12 6 mm NA in vivo
Cuvettes:
CUV-01 2 1 mm V = 100 Al NA ex vivo
CUV-02 2 2 mm V = 400 Al NA ex vivo
CUV-04 2 4 mm V = 800 Al NA ex vivo
Electrode array:
96W-A 96 wells 5.5 mm V = 300 Al/well NA ex vivo
EUROGENTEC http://www.eurogentec.com
CUVETTES: Compatible with most existing electroporation systems
2 1 mm NA Aluminum in vitro
2 2 mm NA Aluminum in vitro
2 4 mm Aluminum in vitro
ICHOR http://www.ichorms.com
Trigrid
multiple NA NA NA in vivo
IGEA http://www.igea.it.
TYPE I: Compatible with Cliniporator
Plate electrodes 2 6 – 8 mm 10 30 mm (rectangular) Stainless steel clinical applications
TYPE II: compatible with cliniporator
Needle rows 8 4 mm L = 20 – 30 mm Stainless steel clinical applications
TYPE III: Compatible with Cliniporator
Hexagonal needle array 7 8 mm L = 20 – 30 mm Stainless steel clinical applications
NA stands for not available.
assembly parts (isolated DC modules, IGBT driver circuitry, such as electrochemotherapy, gene transfer, electroinsertion
etc.), on the other hand, increase the costs of the device, of proteins into cell plasma membrane, electrofusion of cells,
which is a subject of optimization during the design stage. transdermal drug delivery, water treatment and food preser-
vation [5– 7,15,20 –23,55 – 57]. Efficiency of all these appli-
cations strongly depends on parameters of electric pulses,
3. Discussion which are delivered to the treated object using specially
developed electrodes and electronic devices—electropora-
Nowadays electropermeabilization is widely used in var- tors. Both parts of equipment play equally important role in
ious biological, medical, and biotechnological applications process of electropermeabilization, but in this paper we
122 M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124
have focused exclusively on electroporators and advantages addition, researcher must also be able to set the oscilloscope
and disadvantages of techniques used for generating re- before the experiments, which requires additional training.
quired signals (Table 1). At this point we did not discuss Probably there are many more drawbacks (e.g. expensive
how each of the presented techniques can solve different high voltage probes and current probes) of using the
problems like tissue burning, electrolytic contamination, oscilloscope that could be overcome by built in current
etc., since this would require additional analysis of electrode and voltage monitors.
designs and materials. Although today we can find several new studies showing
Besides reviewing known techniques of signal genera- biological effects of nanosecond pulsed electric fields
tion, we also investigated the world market of electropora- [51,52], we did not review the parameters and technologies
tors. A list of existing commercially available electroporators used, since this has already been done by Mankowski et al.
with their parameters, biological applications and possible [49]. In this review, they have presented several short pulse
signal generation technique are given in Table 2. Devices generator technologies such as discharge of capacitor, pulse
are grouped by manufacturer and each device is presented forming line (PFL), Marxx-generator, etc. Besides this they
with the following parameters: output characteristics, volt- also offer a list of commercially available short pulse
age range, time constant (s)/pulse length (T), and charge generators.
time (tc)/pulse repetition frequency ( f). The value of last In conclusion we can say that even though manufacturers
two parameters depends on output characteristic if the offer a brand variety of electroporators and electroporation
device produces exponentially decaying pulses, time con- systems, these devices still have specific limitations. This
stant and charge time are given as parameters. On the other was probably the main reason why many researchers have
hand, if the device generates square wave pulses, pulse developed their own custom-designed devices or systems.
length and pulse repetition frequency are given as param- Since many of these custom-built devices are poorly de-
eters. Since some of manufacturers also offer different scribed in the articles, we were unable to explore their
electrodes for different applications we have also made a parameters in details. What we offer instead is a list of
list that is given in Table 3. Electrodes are grouped by articles describing the devices (see Refs. [43,44,47 – 57]).
manufacturers and each electrode is presented with the
following parameters: electrode type, electrode distance
and biological applications. Acknowledgements
We can see that it is practically impossible to compare
the listed devices due to difference in their characteristics. This research has been supported through various grants
Even if we compare devices with identical output charac- by the Ministry of Education, Science and Sports of the
teristic (e.g. exponential, square wave, arbitrary) we see that Republic of Slovenia and in part by the European project
either their voltage range or their time constant/pulse length Cliniporator QLK3-1999-00484. The authors wish to thank
vary in incomparable range. We believe that with each of the Dr. Maša Kanudšar, Dr. Tadej Kotnik and Gorazd Pucihar
listed devices adequate experimental results can be for many useful suggestions during the preparation of the
achieved, yet some questions still remain. Do we need manuscript.
any special buffers for electropermeabilization of cells?
How can we set the required parameters for electropermea-
bilization (i.e. user friendliness of the device)? Is the device References
modular or non-modular type (i.e. with addition of new
module we extend working parameters)? From this we can [1] K. Kinosita, T.Y. Tsong, Formation and resealing of pores of con-
conclude that manufacturers of the electroporators have to trolled sizes in human erythrocyte membrane, Nature 268 (1977)
standardize electrical parameters of devices, which would 438 – 441.
[2] J. Teissie, T.Y. Tsong, Electric field induced transient pores in phos-
also include list of required buffers that have to be used for
polipid bilayer vesicles, Biochemistry 20 (1981) 1548 – 1554.
efficient electropermeabilization. This has already been [3] E. Neumann, M.S. Ridder, Y. Wang, P.H. Hofschneider, Gene transfer
done by some manufacturers (Eppendorf, BioRad, BTX, into mouse lyoma cells by electroporation in high electric fields,
etc.) who supply protocols and standardized buffers for EMBO J. 1 (1982) 841 – 845.
different procedures. [4] E. Neumann, A.E. Sowers, C.A. Jordan, Electroporation and Electro-
Besides standardization of parameters of devices, manu- fusion in Cell Biology, Plenum, New York, 1989.
[5] L.M. Mir, Therapeutic perspectives of in vivo cell electropermeabili-
facturers should also start offering a built-in module for zation, Bioelectrochemistry 53 (2000) 1 – 10.
current and voltage monitoring. It is very important that [6] E. Neumann, S. Kakorin, K. Toensing, Fundamentals of electropor-
researcher has an immediate feedback about the electro- ative delivery of drugs and genes, Bioelectrochem. Bioenerg. 48
permeabilizing signal that has been delivered to the electro- (1999) 3 – 16.
des. Monitoring of voltage and current can be performed by [7] J. Teissie, N. Eynard, B. Gabriel, M.P. Rols, Electropermeabilization
of cell membranes, Adv. Drug Deliv. Rev. 35 (1999) 3 – 19.
use of an oscilloscope, but this requires additional space for [8] M.P. Rols, J. Teissie, Electropermeabilization of mammalian cells to
another electronic device in already overstuffed laboratory macromolecules: control by pulse duration, Biophys. J. 75 (1998)
and also additional wiring for signal measurements. In 1415 – 1423.
M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124 123
[9] T. Kotnik, L.M. Mir, K. Flisar, M. Puc, D. Miklavčič, Cell membrane medium conductivity on electropermeabilization and survival of cells
electropermeabilization by symmetrical bipolar rectangular pulses: in vivo, Bioelectrochemistry 54 (2001) 107 – 115.
Part I. Increased efficiency of permeabilization, Bioelectrochemistry [31] I.G. Abidor, A.I. Barbul, D.Z. Zhev, P. Doinov, I.N. Bandarina, E.M.
54 (2001) 83 – 90. Osipova, S.I. Sukharev, Electrical properties of cell pallet and cell
[10] T. Kotnik, L.M. Mir, D. Miklavčič, Cell membrane electropermeabi- fusion in centrifuge, Biochim. Biophys. Acta 152 (1994) 207 – 218.
lization by symmetrical bipolar rectangular pulses: Part II. Reduced [32] I.G. Abidor, L.-H. Li, S.W. Hui, Studies of cell pallets: II. Osmotic
electrolytic contamination, Bioelectrochemistry 54 (2001) 91 – 95. properties, electroporation and related phenomena: membrane inter-
[11] M. Puc, T. Kotnik, L.M. Mir, D. Miklavčič, Quantitative model of actions, Biophys. J. 67 (1994) 427 – 435.
small molecules uptake after in vitro cell electropermeabilization, [33] R.V. Davalos, B. Rubinsky, D.M. Otten, A feasibility study for elec-
Bioelectrochemistry 60 (2003) 1 – 10. trical impedance tomography as a means to monitor tissue electro-
[12] G. Pucihar, L.M. Mir, D. Miklavčič, The effect of pulse repetition poration for molecular medicine, IEEE Trans. Biomed. Eng. 49
frequency on the uptake into electropermeabilized cells in vitro with (2002) 400 – 403.
possible analysis and it application, Bioelectrochem. Bioenerg. 57 [34] U. Pliquett, E.A. Gift, J.C. Weaver, Determination of the electric field
(2002) 167 – 172. and anomalous heating caused by exponential pulses with aluminum
[13] T. Kotnik, G. Pucihar, M. Reberšek, D. Miklavčič, L.M. Mir, Role of electrodes in electroporation experiments, Bioelectrochem. Bioenerg.
pulse shape in cell membrane electropermeabilization, Biochim. Bio- 39 (1996) 39 – 53.
phys. Acta 1614 (2003) 193 – 200. [35] U. Friderich, N. Stachowicz, A. Simm, G. Fuhr, K. Lucas, U. Zim-
[14] M. Golzio, M.P. Mora, C. Raynaund, C. Delteil, J. Teissie, M.P. Rols, mermann, High efficiency electrotransfection with aluminum electro-
Control by osmotic pressure of voltage-induced permeabilization and des using microsecond controlled pulses, Bioelectrochem. Bioenerg.
gene transfer in mammalian cells, Biophys. J. 74 (1998) 3015 – 3022. 47 (1998) 103 – 111.
[15] J. Teissie, Transfer of foreign receptors to living cell surfaces: the [36] F. Loste, N. Eynard, J. Teissie, Direct monitoring of the field
bioelectrochemical approach, Bioelectrochem. Bioenerg. 46 (1998) strength during electropulsation, Bioelectrochem. Bioenerg. 47
115 – 120. (1998) 119 – 127.
[16] T. Kotnik, F. Bobanović, D. Miklavčič, Sensitivity of transmembrane [37] T. Tomov, I. Tsoneva, Are the stainless steel electrodes inter? Bio-
voltage induced by applied electric fields: a theoretical analysis, Bio- electrochemistry 51 (2000) 207 – 209.
electrochem. Bioenerg. 43 (1997) 285 – 291. [38] M. Pavlin, T. Slivnik, D. Miklavčič, Effective conductivity of cell
[17] P.J. Canatella, J.F. Karr, J.A. Petros, M.R. Prausnitz, Quantitative suspensions, IEEE Trans. Biomed. Eng. 49 (2002) 77 – 80.
study of electroporation-mediated molecular uptake and cell viability, [39] M. Pavlin, D. Miklavčič, Effective conductivity of a suspension of
Biophys. J. 80 (2001) 755 – 764. permeabilized cells: a theoretical analysis, Biophys. J. 85 (2003)
[18] M. Pavlin, N. Pavšelj, D. Miklavčič, Dependence of induced 719 – 729.
transmembrane potential on cell density, arrangement, and cell [40] R.D. Fomekong, U. Pliquett, F. Pliquett, Passive electrical properties
position inside a cell system, IEEE Trans. Biomed. Eng. 49 or RBC suspensions: changes due to distribution of relaxation times
(2002) 605 – 612. in dependence on the cell volume fraction and medium conductivity,
[19] B. Valič, M. Golzio, M. Pavlin, A. Schatz, C. Faurie, B. Gabriel, J. Bioelectrochem. Bioenerg. 47 (1998) 81 – 88.
Teissie, M.P. Rols, D. Miklavčič, Effect on electric field induced trans- [41] G.A. Hofmann, S.B. Dev, G.S. Nanda, Electrochemotherapy: transi-
membrane potential on spheroidal cells: theory and experiments, Eur. tion from laboratory to clinic, IEEE Eng. Med. Biol. Mag. 15 (1996)
Biophys. J. 32 (2003) 519 – 528. 124 – 132.
[20] M.R. Prausnitz, V.G Bose, R. Langer, J.C. Weaver, Electroporation of [42] M. Okino, H. Tomie, H. Kanesada, M. Marumoto, K. Esato, H.
mammalian skin: a mechanism to enhance transdermal drug delivery, Suzuki, Optimal electric conditions in electrical impulse chemother-
P. Natl. Acad. Sci. U. S. A. 90 (1993) 10504 – 10508. apy, Jpn. J. Cancer Res. 83 (1992) 1095 – 1101.
[21] M.R. Prausnitz, A practical assessment of transdermal drug delivery [43] D.C. Chang, Cell poration and cell fusion using an oscillating electric
by skin electroporation, Adv. Drug Deliv. Rev. 35 (1999) 61 – 67. field, Biophys. J. 56 (1989) 641 – 652.
[22] S.B. Dev, D.P. Rabussay, G. Widera, G.A. Hofmann, Medical applica- [44] M. Puc, K. Flisar, S. Reberšek, D. Miklavčič, Electroporator for in
tions of electroporation, IEEE Trans. Plasma Sci. 28 (2000) 206 – 223. vitro cell permeabilization, Radiol. Oncol. 35 (2001) 203 – 207.
[23] J. Gehl, Electroporation: theory and methods, perspectives for drug [45] M. Puc, S. Reberšek, D. Miklavčič, Requirements for a clinical elec-
delivery, gene therapy and research, Acta Physiol. Scand. 177 (2003) trochemotherapy device—electroporator, Radiol. Oncol. 31 (1997)
437 – 447. 368 – 373.
[24] D. Miklavčič, K. Beravs, D. Šemrov, M. Čemažar, G. Serša, The [46] E. Tekle, R.D. Astumian, P.B. Chock, Electroporation by using
importance of electric field distribution for effective in vivo electro- bipolar oscillating electric field: an improved method foe DNA
poration of tissue, Biophys. J. 74 (1998) 2152 – 2158. transfection of NIH 3T3 cell, P. Natl. Acad. Sci. U. S. A. 88 (1991)
[25] J. Gehl, T.H. Sorensen, K. Nielsen, P. Raskmark, S.L. Nielsen, T. 4230 – 4234.
Skovsgaard, L.M. Mir, In vivo electroporation of skeletal muscle: [47] K. Flisar, M. Puc, T. Kotnik, D. Miklavčič, A system for in vitro cell
threshold, efficacy and relation to electric field distribution, Bio- membrane electropermeabilization with arbitrary pulse waveforms,
chim. Biophys. Acta 1428 (1999) 233 – 240. IEEE Eng. Med. Biol. Mag. 22 (2003) 77 – 81.
[26] G. Serša, M. Čemažar, D. Šemrov, D. Miklavčič, Changing electrode [48] M. Petkovšek, J. Nastran, D. Vončina, P. Zajec, D. Miklavčič, G.
orientation improves the efficacy of electrochemotherapy of solid Serša, High voltage pulse generation, Electron. Lett. 38 (2002)
tumors in mice, Bioelectrochem. Bioenerg. 39 (1996) 61 – 66. 680 – 682.
[27] M.P. Rols, J. Teissie, Ionic-strength modulation of electrically induced [49] J. Mankowski, M. Kristiansen, A review of short pulse generator
permeabilization and associated fusion of mammalian cells, Eur. J. technology, IEEE Trans. Plasma Sci. 28 (2000) 102 – 108.
Biochem. 179 (1989) 109 – 115. [50] Y.C. Lin, C.M. Jen, M.Y. Huang, C.Y Wu, X.Z. Lin, Electroporation
[28] E. Neumann, Membrane electroporation and direct gene transfer, Bio- microchips for continuous gene transfection, Sens. Actuators, B,
electrochem. Bioenerg. 28 (1992) 247 – 267. Chem. 79 (2001) 137 – 143.
[29] C.S. Djuzenova, U. Zimmermann, H. Frank, V.L. Sukhorukov, E. [51] S.J. Beebe, P.M. Fox, L.J. Rec, K. Somers, R.H. Stark, K.H.
Richter, G. Fuhr, Effect of medium conductivity and composition Schoenbach, Nanosecond pulsed electric field (nsPEF) effects on
on the uptake of propidium iodide into electropermeabilized mye- cells and tissues: apoptosis induced and tumor growth inhibition,
loma cells, Biochim. Biophys. Acta 1284 (1996) 143 – 152. IEEE Trans. Plasma Sci. 30 (2002) 286 – 292.
[30] G. Pucihar, T. Kotnik, M. Kandušer, D. Miklavčič, The influence of [52] K.H. Schoenbach, S. Katsuki, R.H. Stark, E.S. Buescher, S.J. Beebe,
124 M. Puc et al. / Bioelectrochemistry 64 (2004) 113–124
Bioelectrics—new applications for pulsed power technology, IEEE Escherichia coli in saline water with high electric field AC, J. Food
Trans. Plasma Sci. 30 (2002) 293 – 300. Eng. 53 (2002) 203 – 207.
[53] A.C. Durieux, R. Bonnefoy, C. Manissolle, D. Freyssenet, High-effi- [56] J. Teissie, N. Eynard, M.C. Vernhes, A. Benichou, V. Ganeva, B.
ciency gene electrotransfer into skeletal muscle: description and phys- Galutzov, P.A. Cabanes, Recent biotechnological developments of
iological applicability of a new pulse generator, Biochem. Biophys. electropulsation. A prospective review, Bioelectrochemistry 55 (2002)
Res. Commun. 296 (2002) 443 – 450. 107 – 112.
[54] S. Šatkauskas, M.F. Bureau, M. Puc, A. Mahfoudi, D. Scherman, D. [57] K. Uemura, S. Isobe, Developing a new apparatus for inactivat-
Miklavčič, L.M. Mir, Mechanisms of in vivo DNA electrotransfer: ing bacillus subtilis spore in orange juice with a high electric
respective contributions of cell electropermeabilization and DNA field AC under pressurized conditions, J. Food Eng. 56 (2003)
electrophoresis, Molec. Ther. 5 (2002) 133 – 140. 325 – 329.
[55] K. Uemura, S. Isobe, Developing a new apparatus for inactivating